share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Novavax | 4: Statement of changes in beneficial ownership of securities

諾瓦瓦克斯醫藥 | 4：持股變動聲明
SEC announcement ·  03/26 19:05
Moomoo AI 已提取核心訊息
James Patrick Kelly, the Executive Vice President, Chief Financial Officer, and Treasurer of Novavax, Inc. (NVAX), has executed a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Kelly after the transaction was not provided. This information is typically crucial for investors to assess the implications of insider transactions on their investment decisions.
James Patrick Kelly, the Executive Vice President, Chief Financial Officer, and Treasurer of Novavax, Inc. (NVAX), has executed a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Kelly after the transaction was not provided. This information is typically crucial for investors to assess the implications of insider transactions on their investment decisions.
Novavax, Inc.（NVAX）執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利已經執行了一項涉及該公司股票的交易。該行動於 2024 年 3 月 1 日進行。但是，該公告沒有透露交易的股票數量、股票的性質、交易價格或股票的總價值。此外，沒有提供凱利在交易後持有的股票數量。這些信息對於投資者評估內幕交易對其投資決策的影響通常至關重要。
Novavax, Inc.（NVAX）執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利已經執行了一項涉及該公司股票的交易。該行動於 2024 年 3 月 1 日進行。但是，該公告沒有透露交易的股票數量、股票的性質、交易價格或股票的總價值。此外，沒有提供凱利在交易後持有的股票數量。這些信息對於投資者評估內幕交易對其投資決策的影響通常至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息